Generic name: estradiol and norethindrone acetate
Dosage form: tablet, film coated
This dosage information does not include all the information needed to use Mimvey safely and effectively. See full prescribing information for Mimvey.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Use of estrogen, alone or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Patients should be re-evaluated periodically as clinically appropriate (e.g., 3 to 6 month intervals) to determine if treatment is still necessary (See BOXED WARNINGS and WARNINGS). For women who have a uterus, adequate diagnostic measures, such as endometrial sampling, when indicated, should be undertaken to rule out malignancy in cases of undiagnosed persistent or recurring abnormal vaginal bleeding.
Mimvey (estradiol and norethindrone acetate tablets, USP) therapy consists of a single tablet to be taken once daily.
1. For the treatment of moderate to severe vasomotor symptoms associated with menopause, and the prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.
2. For the treatment of moderate to severe symptoms of vulvar and vaginal atrophy. When used solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
Patients should be started at the lowest dose.